Free Trial

PHAXIAM Therapeutics (PHXM) SEC Filings & 10K Form

PHAXIAM Therapeutics logo
$3.10 0.00 (0.00%)
(As of 12/24/2024 ET)

Recent PHAXIAM Therapeutics SEC Filings

DateFilerForm TypeView
03/11/2024
7:31 AM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form 15F-12B
03/05/2024
11:15 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form EFFECT
03/04/2024
3:28 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form S-8 POS
03/04/2024
3:25 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form S-8 POS
03/04/2024
3:27 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form S-8 POS
03/04/2024
3:14 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form S-8 POS
03/04/2024
3:22 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form S-8 POS
03/01/2024
3:04 PM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
02/21/2024
5:05 AM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/19/2024
9:04 AM
PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHXM) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners